“CLINICAL OBSERVATION OF THE USE OF ORAL VINORELBINE IN THE TREATMENT OF DISSEMINATED ESTROGEN-RECEPTORPOSITIVE, HER2-NEGATIVE BREAST CANCER”, Wor.Bul.Soc.Sci., vol. 7, pp. 1–4, Feb. 2022, Accessed: Mar. 31, 2026. [Online]. Available: https://scholarexpress.net/index.php/wbss/article/view/514